Dr. Benjamin Lilienfeld holds a masters and a PhD degree in Molecular Biology and Immunology from the University of Zurich, Switzerland. He joined Roche in 2008 as an International Product Manager for Infectious Diseases in the headquarter in Switzerland and was responsible for hepatitis serology. From 2011 to 2014 he was Regional Business Manager for Roche Molecular Systems based in Singapore where he took care of the Virology and Blood Screening NAT products. Benjamin then joined the German country organization in 2014 where he was Head of Marketing for the SWA Franchise before he returned to the headquarters in Switzerland in the middle of 2017 to become International Business Leader for the SWA Systems. Since 2021, Benjamin has been the Lifecycle Leader for the Serum Work Area (SWA) systems. In this role he is responsible for the overall strategy of the clinical chemistry, immunochemistry and mass spectrometry instrument portfolio including product development and commercialization.
He joined Roche in 2008 as an International Product Manager for Infectious Diseases in the headquarter in Switzerland and was responsible for hepatitis serology. From 2011 to 2014 he was Regional Business Manager for Roche Molecular Systems based in Singapore where he
took care of the Virology and Blood Screening NAT products.
Benjamin then joined the German country organization in 2014 where he was Head of Marketing for the SWA Franchise before he returned to the headquarters in Switzerland in the middle of 2017 to become International Business Leader for the SWA Systems.
Since 2021, Benjamin has been the Lifecycle Leader for the Serum Work Area (SWA) systems. In this role he is responsible for the overall strategy of the clinical chemistry, immunochemistry and mass spectrometry instrument portfolio including product development and commercialization.
